AI Article Synopsis

  • The study assessed a program where pharmacists used handheld doppler devices to screen at-risk patients for peripheral arterial disease (PAD).
  • In a prospective setting, 41 patients over 55 without a history of PAD participated, undergoing questionnaires and doppler examinations.
  • Out of the participants, 19.5% were diagnosed with PAD, leading to treatment or referrals, demonstrating the program's effectiveness in identifying previously undiagnosed cases.

Article Abstract

Study Objective: To evaluate the effectiveness of a program in which pharmacists screened at-risk patients for peripheral arterial disease using a handheld doppler device.

Design: Prospective study.

Setting: Primary care and consultative outpatient clinic.

Patients: Forty-one physician-referred patients older than 55 years who had no documented history of peripheral arterial disease.

Intervention: The pharmacists administered the San Diego Claudication Questionnaire and performed doppler examinations to calculate ankle-to-brachial indexes (ABIs). Patients with symptoms of claudication or with an ABI of 0.9 or less were considered to have possible peripheral arterial disease. Each diagnosis was confirmed by a physician. These patients were either referred for further evaluation, provided with immediate treatment, or told to continue their current drug regimen, if appropriate.

Measurements And Main Results: Eight (19.5%) of the 41 patients were diagnosed with peripheral arterial disease. Antiplatelet therapy was started in five patients, and one patient was referred to a vascular specialist.

Conclusion: This pharmacist-initiated program effectively detected peripheral arterial disease in previously unscreened patients.

Download full-text PDF

Source
http://dx.doi.org/10.1592/phco.2005.25.6.797DOI Listing

Publication Analysis

Top Keywords

peripheral arterial
24
arterial disease
20
disease handheld
8
handheld doppler
8
patients
7
peripheral
6
arterial
6
disease
5
pharmacist detection
4
detection peripheral
4

Similar Publications

Introduction: The efficacy of lipoprotein apheresis (LA) in peripheral arterial disease (PAD) has been primarily attributed to its anti-atherosclerotic effects through the adsorption of lipoproteins. However, the other potential effects of LA remain unknown. We evaluated changes in serum profiles before and after LA using a comprehensive analysis to explore the underlying mechanism.

View Article and Find Full Text PDF

Background: Despite advancements in valve implantation devices, vascular access complications (VAC) remain a significant cause of morbidity and mortality for those undergoing transcatheter aortic valve replacement (TAVR). We describe pre-operative imaging analysis of the aortoiliac and femoral arterial beds using the TransAtlantic intersociety consensus (TASC) score, ilio-femoral tortuosity, and procedural characteristics to identify anatomic risk factors predictive of VAC in TAVR.

Methods: Consecutive patients undergoing TAVR from 2012 to 2022 at a single North Dakota hospital were retrospectively reviewed.

View Article and Find Full Text PDF

Background: Bronchial artery pseudoaneurysm is a rare vascular disorder, and cases of bronchial pseudoaneurysms reported after lung surgery are even rarer. The number of reported cases is very limited due to the unclear pathogenesis, lack of diagnostic criteria and treatment guidelines, and nonspecific clinical manifestations.

Case Presentation: The paper reports a case of a patient with primary lung adenocarcinoma who developed hemoptysis, chest and back pain, and right hemothorax after lobectomy.

View Article and Find Full Text PDF

Proliferative diabetic retinopathy (PDR) and peripheral arterial disease (PAD) of the lower extremities are serious complications of type 2 diabetes mellitus (T2DM). Aerobic exercise has been shown to be primarily effective for glycemic control and gait disturbance owing to PAD. However, the safety and efficacy of exercise therapy in patients with PDR remain unclear.

View Article and Find Full Text PDF

Background: To date, no specific treatment has been established to reverse progressive chronic kidney disease (CKD).

Aim: To evaluate the safety and efficacy of autologous CD34 cell transplantation in CKD patients who exhibited a progressive decline in renal function.

Methods: The estimated glomerular filtration rate (eGFR) at the beginning of the study was 15.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!